Patricia Colp

Patricia Colp

Auto-generated profile, based on publicly available information

Patricia Colp

Department of Pathology, Faculty of Medicine, Dalhousie University, 5849 University Avenue, Halifax, NS B3H 4R2, Canada

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 May 2020 in Antibiotics
Verified
Journal Article
Open access
PDF file
DFDanielle Fokam
Danielle Fokam
KDKayle Brenna Dickson
Kayle Brenna Dickson
KKKiyana Kamali
Kiyana Kamali
BHBruce Holbein
Bruce Holbein
PCPatricia Colp
Patricia Colp
Christian LehmannChristian Lehmann
Christian Lehmann
Iron is an essential element for various physiological processes, but its levels must remain tightly regulated to avoid cellular damage. Similarly, iron plays a dual role in systemic inflammation, such as with sepsis. Leukocytes utilize iron to produce reactive oxygen species (ROS) to kill bacteria, but pathologically increased iron-catalyzed ROS production in sepsis can lead to damage of host cells, multi-organ failure and death. Temporary reduction in bioavailable iron represents a potential therapeutic target in sepsis. This study investigates the effect of the novel iron chelator, DIBI, in murine models of systemic (hyper-)inflammation: C57BL/6 mice were challenged with toxins from Gram-positive (Staphylococcus aureus: lipoteichoic acid, peptidoglycan) and Gram-negative bacteria (Escherichia coli and Klebsiella pneumoniae: lipopolysaccharide). Intravital microscopy (IVM) was performed to assess immune cell activation and its impact on microvascular blood flow in vivo in the microcirculation of the gut. Plasma inflammatory mediators were measured via multiplex assay, and morphologic change in intestinal tissue was evaluated. DIBI treatment decreased leukocyte (hyper-)activation induced by Gram-positive and Gram-negative toxins. In some cases, it preserved capillary perfusion, reduced plasma inflammatory markers and attenuated tissue damage. These findings support the utility of DIBI as a novel treatment for systemic inflammation, e.g., sepsis.

7 December 2020 in Cancers
Verified
Journal Article
Open access
PDF file
Alamelu BharadwajAlamelu Bharadwaj
Alamelu Bharadwaj
MTMargaret L. Thomas
Margaret L. Thomas
Rongzong LiuRongzong Liu
Rongzong Liu
PCPatricia Colp
Patricia Colp
LTLynn N. Thomas
Lynn N. Thomas
David WaismanDavid Waisman
David Waisman
S100A10 (p11) is a plasminogen receptor that regulates cellular plasmin generation by cancer cells. In the current study, we used the MMTV-PyMT mouse breast cancer model, patient tumor microarray, and immunohistochemical (IHC) analysis to investigate the role of p11 in oncogenesis. The genetic deletion of p11 resulted in significantly decreased tumor onset, growth rate, and spontaneous pulmonary metastatic burden in the PyMT/p11-KO (knock-out) mice. This phenotype was accompanied by substantial reduction in Ki67 positivity, macrophage infiltration, decreased vascular density in the primary tumors, and decrease in invasive carcinoma and pulmonary metastasis. Surprisingly, IHC analysis of wild-type MMTV-PyMT mice failed to detect p11 expression in the tumors or metastatic tumor cells and loss of p11 did not decrease plasmin generation in the PyMT tumors and cells. Furthermore, tumor cells expressing p11 displayed dramatically reduced lung metastasis when injected into p11-depleted mice, further strengthening the stromal role of p11 in tumor growth and metastasis. Transcriptome analysis of the PyMT tumors from p11-KO mice showed marked reduction in genes such as Areg, Muc1, and S100a8 involved in breast cancer development, progression, and inflammation. The PyMT/p11-KO tumors displayed a remarkable increase in inflammatory cytokines such as interleukin (Il)-6, Il-10, and interferon (Ifn)-γ. Gene expression profiling and IHC of primary breast cancer samples showed that p11 mRNA and protein levels were significantly higher in tumor tissues compared to normal mammary tissue. P11 mRNA expression was significantly associated with poor patient prognosis and significantly elevated in high grade, triple negative (TN) tumors, and tumors with high proliferative index. This is the first study examining the crucial role of p11 in breast tumor development and metastasis, thus emphasizing its potential as a diagnostic and prognostic biomarker in breast cancer.

Verified
Journal Article
Open access
PDF file
YGYang Gu
Yang Gu
AKAshley Kervin
Ashley Kervin
PCPatricia Colp
Patricia Colp
Given higher compatible rates between oral lichen planus (OLP) and oral lichenoid lesions (OLLs) in histopathological and clinical features, this study aims to delineate a boundary between equivocal OLP and OLLs by biomarkers. The updated OLP diagnostic criteria in 2016 was our guideline in defining study cases of typical OLP and typical OLL with triggers, which include topical offending agents (OLL-agent), dental restorations (OLL-dental), and systemic offending drugs (OLL-drug). The expression intensity and distribution patterns of CD4, CD8, and CGRP in four groups were detected by immunohistochemistry assay (IHC). A total of 79 cases including OLP (24), OLL-agent (15), OLL-dental (21), and OLL-drug (19) were collected from an oral biopsy laboratory. Band-like distribution patterns of CD4 (100%, score 3), CD8 (54.17%, score 2), and CGRP (87.5%, score 3) in the subepithelial regions of the OLP group significantly differ from the OLL groups (each comparison pair, p = 0.0001). The sensitivity of CD4 (100%), specificity of CD4 (83.64%), negative predictive value of CD4 (100%), and accuracy of CD4 (83.80%) in the OLP group provide results for the diagnostic test evaluation. The band-like distribution pattern of CD4 in the subepithelial region may determine OLP when the biopsy specimen does not show typical microscopic features.